Food And Drug Administration

ACI Urges FDA to Address Hand Sanitizer Safety Concerns

The American Cleaning Institute (ACI) is pressing the U.S. Food and Drug Administration (FDA) to clarify policies on labeling and refilling practices involving hand sanitizers.

In a letter sent to the agency, ACI expressed concerns related to the “new, increasingly widespread practice of providing hand sanitizers to consumers in public settings…that are often sold in bulk and used to fill existing dispensers, which can create a serious risk to public health and safety.”

UCLA, UCSF gain FDA approval for prostate cancer imaging technique

The University of California’s two nationally ranked medical centers, UCSF and UCLA, and their nuclear medicine teams have obtained approval from the U.S. Food and Drug Administration to offer a new imaging technique for prostate cancer that locates cancer lesions in the pelvic area and other parts of the body to which the tumors have migrated.

Food Safety and Coronavirus

Covid Conversations on Risk featuring Jade Mitchell, Ph.D., and Felicia Wu, Ph.D. both from Michigan State University addresses food safety and risk. A recording of the webinar can be found on the SRA website at https://sra.org/covid-19-resources

New Legislation Would Jeopardize Patient Access to Medical Tests Across the Board by Restricting Policy that Removed Barriers to Coronavirus Testing

On March 5, U.S. House and Senate lawmakers introduced the VALID Act, which would give the Food and Drug Administration (FDA) new, expansive powers to regulate laboratory developed tests—tests that are already regulated by the Centers for Medicare and Medicaid Services (CMS) and are subject to stringent personnel, quality control, and proficiency testing requirements. This bill promotes duplicative, costly federal regulations for clinical laboratories that will result in decreased patient access to essential medical tests. AACC urges Congress not to act on this bill until its impact on healthcare can be thoroughly evaluated.